Appendix 1: Policy Indicators and Sub-Indicators Included in Analysis, by Category
Category Name Indicator or Sub-Indicator
Clinical care and treatment Treatment initiation Indicator
Same-day treatment start Indicator
Treatment regimen Indicator
Differentiated service delivery Indicator
Differentiated service delivery – Community ART distribution Sub-indicator
Differentiated service delivery – Clinical visit frequency Sub-indicator
Differentiated service delivery – Multi-month dispensing Sub-indicator
Viral load testing Indicator
Pediatric diagnosis and treatment Indicator
Pediatric diagnosis and treatment – Pediatric diagnosis Sub-indicator
Pediatric diagnosis and treatment – Pediatric treatment Sub-indicator
Migrants’ access to health care Indicator
Migrants’ access to health care – Primary health care Sub-indicator
Migrants’ access to health care – HIV health care Sub-indicator
Tuberculosis diagnostics Indicator
Testing and prevention Self-testing Indicator
Partner notification/Index testing Indicator
Partner notification/Index testing – Index testing Sub-indicator
Partner notification/Index testing – Confidentiality in index testing Sub-indicator
Compulsory testing Indicator
Age restrictions on testing and treatment Indicator
PrEP Indicator
PrEP – Policy Sub-indicator
PrEP – Regulatory approval Sub-indicator
Harm reduction Indicator
Harm reduction – Harm reduction strategy Sub-indicator
Harm reduction – Syringe non-criminalization Sub-indicator
Comprehensive sexuality education Indicator
Prisoner prevention Indicator
Prisoner prevention – Condoms Sub-indicator
Prisoner prevention – Needle and syringe exchange program Sub-indicator
Health systems Task shifting Indicator
Health financing Indicator
Health financing – Budget Sub-indicator
Health financing – Tax revenue Sub-indicator
Universal health coverage Indicator
Universal health coverage – ARVs Sub-indicator
Universal health coverage – PrEP Sub-indicator
User fees Indicator
User fees – Primary care Sub-indicator
User fees – HIV services Sub-indicator
Access to medicines (TRIPS) Indicator
Access to medicines (TRIPS) – Incorporation Sub-indicator
Access to medicines (TRIPS) – Use Sub-indicator
Unique identifiers with data protections Indicator
Unique identifiers with data protections – Unique identifiers use Sub-indicator
Unique identifiers with data protections – Data protections Sub-indicator
Data sharing Indicator
Data sharing – Disaggregation Sub-indicator
Data sharing – Frequency Sub-indicator
Structural Same-sex sex non-criminalization Indicator
Same-sex sex non-criminalization – Laws Sub-indicator
Same-sex sex non-criminalization – Arrests Sub-indicator
Sex work non-criminalization Indicator
Drug use non-criminalization Indicator
HIV exposure non-criminalization Indicator
HIV exposure non-criminalization – Laws Sub-indicator
HIV exposure non-criminalization – Arrests Sub-indicator
Non-discrimination protections Indicator
Non-discrimination protections – Sexual orientation Sub-indicator
Non-discrimination protections – Gender identity Sub-indicator
Non-discrimination protections – HIV status Sub-indicator
National human rights institutions Indicator
Constitutional right to health Indicator
Girls’ education Indicator
Civil society Indicator
Civil society – Social contracting Sub-indicator
Civil society – Freedom Sub-indicator
NOTE: Please see the HIV Policy Lab codebook for indicator and sub-indicator definitions.
Findings

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.